Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Agromedicine|October 5, 2017
Chronic Disease and Health Risk Behaviors Among Rural Agricultural Workforce in QueenslandJanani Pinidiyapathirage, Megan O'Shannessy, Jane Harte, et al.
Emergency Medicine Australasia : EMA|December 12, 2018
Analysis of agriculture-related life-threatening injuries presenting to emergency departments of rural generalist hospitals in Southern QueenslandJanani Pinidiyapathirage, Scott Kitchener, Sarah McNamee, et al.
The Australian Journal of Rural Health|April 6, 2019
Prevalence and outcomes of overweight and obesity among pregnant women in rural QueenslandLynsey Cochrane, Kay Brumpton, Sacha Winter, et al.
Vaccine|October 11, 2005
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adultsScott Kitchener, Michael Nissen, Peter Nasveld, et al.
The Australian Journal of Rural Health|May 19, 2015
Longlook: initial outcomes of a longitudinal integrated rural clinical placement programScott Kitchener, Renee Day, Daniel Faux, et al.
Journal of Travel Medicine|November 16, 2004
Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelersJulian H Elliott, Daniel O'Brien, Karin Leder, et al.
The Australian Journal of Rural Health|July 27, 2019
Epidemiology of melanoma in rural southern QueenslandScott Kitchener, Janani Pinidiyapathirage, Keegan Hunter, et al.
Human Vaccines|October 3, 2006
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypesFarshad Guirakhoo, Scott Kitchener, Dennis Morrison, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Pageof 3